Synopsys (SNPS) Tops Q1 EPS by 13c
Tweet
Share
E-mail
Get Alerts SNPS Hot Sheet
Price: $412.32 --0%
Revenue Growth %: +40.2%
Financial Fact:
Research and development: 221.95M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Revenue Growth %: +40.2%
Financial Fact:
Research and development: 221.95M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Synopsys (NASDAQ: SNPS) reported Q1 EPS of $3.56, $0.13 better than the analyst estimate of $3.43. Revenue for the quarter came in at $1.65 billion versus the consensus estimate of $1.65 billion.
For earnings history and earnings-related data on Synopsys (SNPS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
- Legence Corp. (LGN) Misses Q2 EPS by 58c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
